Concepedia

Jayakumar Vadakekolathu

JV

Statistics

Publications

32

Citations

1.7K

H-Index

21

Active since

2013

Affiliations

Nottingham Trent University(Current)

Nanostring Technologies (United States)

University Hospital Carl Gustav Carus

University of Bologna

MacroGenics (United States)

Jayakumar Vadakekolathu is an author at Nottingham Trent University specializing in oncology, cancer immunotherapy, and medicine.

ORCID

Publications per year

2013–2023

32

Publications

32

Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia

Geoffrey L. Uy, Ibrahim Aldoss, Matthew C. Foster et al. · Blood · 2020 · 322 citations · Full text

, , +13

Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia

Jayakumar Vadakekolathu, Mark D. Minden, Tressa Hood et al. · Science Translational Medicine · 2020 · 209 citations · Full text

, , +16

TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML

Jayakumar Vadakekolathu, Catherine Lai, Stephen Reeder et al. · Blood Advances · 2020 · 153 citations · Full text

, , +17

Immune dysfunction signatures predict outcomes and define checkpoint blockade–unresponsive microenvironments in acute myeloid leukemia

Sergio Rutella, Jayakumar Vadakekolathu, Francesco Mazziotta et al. · Journal of Clinical Investigation · 2022 · 92 citations · Full text

, , +17

Immune-Phenotyping and Transcriptomic Profiling of Peripheral Blood Mononuclear Cells From Patients With Breast Cancer: Identification of a 3 Gene Signature Which Predicts Relapse of Triple Negative Breast Cancer

Gemma A. Foulds, Jayakumar Vadakekolathu, Tarek M.A. Abdel-Fatah et al. · Frontiers in Immunology · 2018 · 77 citations · Full text

, , +17

1–5 of 32